Methylene Blue 1% Inj, 10ml

Methylene Blue acts as an electron acceptor in the NADPH-methemoglobin reductase pathway, converting methemoglobin back to hemoglobin. It is reduced to leucomethylene blue by NADPH-methemoglobin reductase, which then reduces the ferric iron (Fe3+) of methemoglobin to the ferrous iron (Fe2+) of hemoglobin. At high concentrations, it can paradoxically oxidize hemoglobin to methemoglobin. It also has monoamine oxidase A (MAO-A) inhibitory properties and can inhibit guanylate cyclase.

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of electrolyte problems, including:
+ Mood changes
+ Confusion
+ Muscle pain, cramps, or spasms
+ Weakness
+ Shakiness
+ Change in balance
+ Abnormal heartbeat
+ Seizures
+ Loss of appetite
+ Severe upset stomach or vomiting
Dizziness or fainting
Confusion
Changes in vision
Feeling extremely tired or weak
Pale skin
Dark urine or yellowing of the skin or eyes
Seizures

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only mild ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other unusual symptoms, contact your doctor for advice:

Urine or stool turning blue or green (this is a normal and harmless effect)
Skin turning blue-green
Pain, redness, or swelling at the injection site
Diarrhea or stomach upset
Headache

Reporting Side Effects

This list is not exhaustive, and you may experience other side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have a condition called G6PD deficiency.
If you are pregnant or think you might be pregnant. This medication may pose a risk to the unborn baby, so it is crucial to discuss the potential benefits and risks with your doctor to determine if this medication is suitable for you.
If you are breastfeeding. You should not breastfeed while taking this medication or for 8 days after your last dose.

This list is not exhaustive, and it is vital to disclose all your medications (including prescription, over-the-counter, natural products, and vitamins) and health issues to your doctor and pharmacist. They will help you verify that it is safe to take this medication in combination with your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular monitoring is crucial, so be sure to undergo blood work, other laboratory tests, blood pressure checks, and heart rate assessments as directed by your doctor. Additionally, you will need to have your heart rhythm checked with an electrocardiogram (ECG) as scheduled.

As this medication may interfere with certain laboratory tests, it is vital to disclose that you are taking this drug to all your healthcare providers and laboratory personnel.

To ensure your safety, avoid operating a vehicle or engaging in activities that require alertness until you are aware of how this medication affects you. You may be more susceptible to sunburn, so it is recommended to limit your exposure to the sun, sunlamps, and tanning beds. When going outside, protect yourself from the sun by using sunscreen and wearing protective clothing and eyewear.

• Serotonergic drugs (e.g., SSRIs, SNRIs, MAOIs, tricyclic antidepressants, triptans, buspirone, tramadol, fentanyl, St. John's Wort) - risk of serotonin syndrome.
• Drugs that cause methemoglobinemia (e.g., dapsone, nitrates, nitrites, local anesthetics like prilocaine, benzocaine) - may exacerbate methemoglobinemia or reduce methylene blue efficacy.
• G6PD deficient patients (risk of hemolytic anemia).

• Any drug that increases serotonin levels (see contraindicated list).
• Drugs that inhibit CYP2D6 (e.g., quinidine, fluoxetine, paroxetine) - may increase methylene blue levels.
• Drugs that are substrates of CYP2D6 (e.g., tricyclic antidepressants, antipsychotics, beta-blockers) - methylene blue is a potent CYP2D6 inhibitor, potentially increasing levels of these drugs.

• Drugs that inhibit CYP1A2, CYP2C19, CYP3A4 (potential for altered methylene blue metabolism).
• Drugs that are substrates of CYP1A2, CYP2C19, CYP3A4 (methylene blue is a moderate inhibitor, potential for altered drug levels).

• None specifically identified as minor; most interactions are significant due to MAO-A inhibition or CYP inhibition.

• Cyanosis (especially of lips, nail beds)
• Dyspnea
• Headache
• Dizziness
• Fatigue
• Confusion
• Tachycardia
• Chest pain
• Nausea/vomiting
• Abdominal pain
• Diaphoresis
• Serotonin syndrome symptoms (agitation, hyperthermia, rigidity, clonus, hyperreflexia, tremor, diaphoresis, diarrhea) - if co-administered with serotonergic drugs.

Use with caution during pregnancy only if the potential benefit justifies the potential risk to the fetus. Methylene Blue crosses the placenta and has been associated with hemolytic anemia and hyperbilirubinemia in neonates, particularly in G6PD deficient infants. Category C.

Methylene Blue is excreted into breast milk. Due to the potential for serious adverse reactions in the breastfed infant (e.g., hemolytic anemia), breastfeeding is not recommended during treatment and for up to 5 days after the last dose. L3 (Moderately Safe - use with caution).

Dosing adjustments are necessary for neonates (lower dose). Use with extreme caution in neonates due to immature enzyme systems and increased risk of hyperbilirubinemia and hemolytic anemia. G6PD deficiency is more common in certain populations, and screening is crucial.

No specific dose adjustments are generally required based on age alone, but elderly patients may have reduced renal or hepatic function, requiring caution and close monitoring. Start with lower doses and titrate carefully.

• Methylene Blue is the first-line treatment for symptomatic methemoglobinemia.
• Always check for G6PD deficiency before administration if possible, but do not delay treatment in severe, symptomatic methemoglobinemia if status is unknown.
• High doses (>7 mg/kg cumulative) can paradoxically cause or worsen methemoglobinemia.
• Patients will experience blue/green discoloration of urine, stool, and potentially skin/mucous membranes; this is a normal and expected side effect.
• Co-administration with serotonergic drugs is contraindicated due to the risk of serotonin syndrome; a washout period may be required for some serotonergic drugs before methylene blue administration.
• Pulse oximetry readings may be falsely low or inaccurate in the presence of methemoglobinemia; co-oximetry is essential for accurate methemoglobin level measurement.
• Methylene Blue can interfere with certain laboratory tests, including those that rely on spectrophotometry (e.g., bilirubin, creatinine, glucose).
• Consider alternative treatments like exchange transfusion or hyperbaric oxygen for severe methemoglobinemia in G6PD deficient patients or those unresponsive to methylene blue.

• Ascorbic Acid (Vitamin C) - for mild methemoglobinemia or in G6PD deficient patients (slower acting, less effective).
• Exchange Transfusion - for severe, refractory methemoglobinemia or in G6PD deficient patients with severe symptoms.
• Hyperbaric Oxygen Therapy - for severe, refractory methemoglobinemia.

If your symptoms or health problems persist or worsen, it is essential to contact your doctor for further guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed to do so by a healthcare professional, avoid flushing medications down the toilet or pouring them down the drain. If you are unsure about the correct disposal method, consult your pharmacist for advice. Additionally, you may want to inquire about potential drug take-back programs in your area. Some medications may come with a separate patient information leaflet, so be sure to check with your pharmacist. If you have any questions or concerns about your medication, do not hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it occurred.